pe
pep-05197 v1 CC-BY-SA-4.0

Cancer-fighting peptide

A peptide studied for its ability to fight cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length60 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.495
avg pLDDT67.8
ranking score0.641
STRUCTURE · PEP-05197 × ANTICANCER
ranking0.641
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence60 aa
151015202530354045505560
LVATGMAAGVAKTIVNAVSA GMDIATALSLFSGAFTAAGG IMALIKKYAQKKLWKQLIAA
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.6414114832878113 boltz-2
3-letter notation
Leu-Val-Ala-Thr-Gly-Met-Ala-Ala-Gly-Val-Ala-Lys-Thr-Ile-Val-Asn-Ala-Val-Ser-Ala-Gly-Met-Asp-Ile-Ala-Thr-Ala-Leu-Ser-Leu-Phe-Ser-Gly-Ala-Phe-Thr-Ala-Ala-Gly-Gly-Ile-Met-Ala-Leu-Ile-Lys-Lys-Tyr-Ala-Gln-Lys-Lys-Leu-Trp-Lys-Gln-Leu-Ile-Ala-Ala
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Cancer-fighting peptide (pep-05197, v1). PeptideModel. https://peptidemodel.com/card/pep-05197
@peptide{pep05197,
  sequence = {LVATGMAAGVAKTIVNAVSAGMDIATALSLFSGAFTAAGGIMALIKKYAQKKLWKQLIAA},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
references 1 papers
[1]
Characterization of Garvicin ML, a Novel Circular Bacteriocin Produced by Lactococcus garvieae DCC43, Isolated from Mallard Ducks ( Anas platyrhynchos )
Borrero J; Brede D; Skaugen M; Diep D; Herranz C; Nes I; Cintas L; Hernández P Applied and Environmental Microbiology 2011
source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use